Skip to main content
logo
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.215
-0.235 (-16.21%)
At close: Nov 6, 2026, 4:00 PM EST
1.280
+0.065 (5.33%)
After-hours: Nov 6, 2026, 7:59 PM EST

Inovio Pharmaceuticals Revenue

In the year 2025, Inovio Pharmaceuticals had annual revenue of $65.34K, down -69.99%. That makes Inovio Pharmaceuticals the 46,389th largest company in the world by revenue and 6,903rd in the United States.

Revenue (ttm)
$65.34K
Revenue Growth
-69.99%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
112
Market Cap
205.25M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202565.34K-152.41K-69.99%
Dec 31, 2024217.76K-614.25K-73.83%
Dec 31, 2023832.01K-9.43M-91.89%
Dec 31, 202210.26M8.49M478.23%
Dec 31, 20211.77M-5.64M-76.05%
Dec 31, 20207.41M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
MacroGenics175.14M
Sutro Biopharma45.70M
Atrium Therapeutics35.84M
Zentalis Pharmaceuticals26.87M
Oramed Pharmaceuticals2.00M
Revenue Rankings

INO News

More News